**Core Concept**
The Philadelphia chromosome is a type of chromosomal abnormality resulting from a reciprocal translocation between chromosomes 9 and 22, leading to the creation of a BCR-ABL fusion gene. This genetic mutation is commonly associated with chronic myeloid leukemia (CML) and certain types of acute lymphoblastic leukemia (ALL).

**Why the Correct Answer is Right**
The presence of the Philadelphia chromosome is a hallmark of CML and is associated with a worse prognosis in this disease. The BCR-ABL fusion gene leads to uncontrolled proliferation of leukemic cells, making CML more aggressive and harder to treat. The presence of the Philadelphia chromosome also makes CML resistant to conventional chemotherapy and requires targeted therapy with tyrosine kinase inhibitors (TKIs).

**Why Each Wrong Option is Incorrect**
**Option A:** Acute myeloid leukemia (AML) - While AML is a type of leukemia, the Philadelphia chromosome is not as commonly associated with AML as it is with CML or certain types of ALL.
**Option B:** Chronic lymphocytic leukemia (CLL) - CLL is a different type of leukemia that does not typically involve the Philadelphia chromosome.
**Option C:** Hodgkin lymphoma - Hodgkin lymphoma is a type of lymphoma that is not associated with the Philadelphia chromosome.

**Clinical Pearl / High-Yield Fact**
The Philadelphia chromosome is a classic example of a chromosomal abnormality that has significant implications for patient prognosis and treatment. Remember that the presence of the Philadelphia chromosome is a key factor in differentiating CML from other types of leukemia.

**Correct Answer: D. Chronic myeloid leukemia (CML).**